These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30242873)

  • 1. CRNDE promotes cell tongue squamous cell carcinoma cell growth and invasion through suppressing miR-384.
    Ren Y; He W; Chen W; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Chai J; Sun M
    J Cell Biochem; 2019 Jan; 120(1):155-163. PubMed ID: 30242873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA CASC15 promotes tongue squamous carcinoma progression through targeting miR-33a-5p.
    Zuo Z; Ma L; Gong Z; Xue L; Wang Q
    Environ Sci Pollut Res Int; 2018 Aug; 25(22):22205-22212. PubMed ID: 29804249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA GIHCG enhanced tongue squamous cell carcinoma progression through regulating miR-429.
    Ma L; Wang Q; Gong Z; Xue L; Zuo Z
    J Cell Biochem; 2018 Nov; 119(11):9064-9071. PubMed ID: 29953645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis.
    Liu M; Liu Q; Fan S; Su F; Jiang C; Cai G; Wang Y; Liao G; Lei X; Chen W; Bi J; Cheng W; Zhao L; Ruan Y; Li J
    Cell Death Dis; 2021 Feb; 12(2):144. PubMed ID: 33542221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR-375 expression.
    Zhang K; Wang Q; Zhong B; Gong Z
    J Cell Mol Med; 2021 May; 25(10):4543-4550. PubMed ID: 33787082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion.
    Sun L; Liang J; Wang Q; Li Z; Du Y; Xu X
    Cell Prolif; 2016 Oct; 49(5):628-35. PubMed ID: 27571935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CACS15 regulates tongue squamous cell carcinoma cell behaviors and predicts survival.
    Wu X; Ma J; Chen J; Huang H
    BMC Oral Health; 2019 Oct; 19(1):231. PubMed ID: 31665008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior].
    Jia LF; Gan YH; Yu GY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):5-9. PubMed ID: 26885901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2.
    Ding J; Yang C; Yang S
    J Oral Pathol Med; 2018 May; 47(5):468-476. PubMed ID: 29315846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 11. TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543/Yes-associated protein 1 axis regulation.
    He S; Wang X; Zhang J; Zhou F; Li L; Han X
    Cell Cycle; 2020 Aug; 19(15):1969-1982. PubMed ID: 32615889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
    Qiu K; Huang Z; Huang Z; He Z; You S
    Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNHG17 enhances the malignant characteristics of tongue squamous cell carcinoma by acting as a competing endogenous RNA on microRNA-876 and thereby increasing specificity protein 1 expression.
    Liu X; Zhang B; Jia Y; Fu M
    Cell Cycle; 2020 Mar; 19(6):711-725. PubMed ID: 32089063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.
    Wei T; Cong X; Wang XT; Xu XJ; Min SN; Ye P; Peng X; Wu LL; Yu GY
    Oncotarget; 2017 Jan; 8(4):6663-6680. PubMed ID: 28035060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GACAT1 induces tongue squamous cell carcinoma migration and proliferation via miR-149.
    Wang X; Gong Z; Ma L; Wang Q
    J Cell Mol Med; 2021 Sep; 25(17):8215-8221. PubMed ID: 34378327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression.
    Bai X; Wang W; Zhao P; Wen J; Guo X; Shen T; Shen J; Yang X
    Carcinogenesis; 2020 Mar; 41(1):111-121. PubMed ID: 31605132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7.
    Zhao J; Hu C; Chi J; Li J; Peng C; Yun X; Li D; Yu Y; Li Y; Gao M; Zheng X
    Oncol Rep; 2016 Aug; 36(2):1143-9. PubMed ID: 27350307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
    J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
    Zheng J; Li XD; Wang P; Liu XB; Xue YX; Hu Y; Li Z; Li ZQ; Wang ZH; Liu YH
    Oncotarget; 2015 Sep; 6(28):25339-55. PubMed ID: 26231038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.